MAXIMUS, INC. (MMS) vs. DuPont de Nemours, Inc. (DD) Stock Comparison & Valuation | Edwyn

Edwyn

Edwyn Search companies, tickers, CIKs…⌘K

MAXIMUS, INC. (MMS) vs. DuPont de Nemours, Inc. (DD) Stock Comparison & Valuation | Edwyn

Updated 2026-07-05 19:48 UTC

This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.

MMS screens as materially undervalued versus DD on every relevant trading multiple while also showing stronger profitability and much cleaner earnings quality, though the valuation gap appears too extreme to rely on the raw P/S comparison alone.

Actionable Takeaway

If you believe MMS can sustain its positive growth, 9.7% operating margin, and 19.1% ROIC while the market continues to normalize valuation to DD-like levels, then MMS looks attractive on a relative basis because it is far cheaper than DD despite better fundamentals; however, DD-implied upside should be treated cautiously because the DCF and historical range are far closer to the current price.

MMS trades at 0.5x P/S, 10.1x P/E, and 6.1x EV/EBITDA versus DD at 8.4x P/S, -75.2x P/E, and 126.1x EV/EBITDA, implying a very large relative discount for MMS. The model’s implied price of $835.09 versus the current $55.75 suggests a 1397.9% upside, but that outcome is driven by DD-multiple framework and is far above both the historical band and DCF range.

Supporting Metrics

Key Risks

DD-multiple valuation is likely overstated because the implied price of $835.09 sits far above the DCF range of $61.20-$82.80.
MMS’s leverage is not zero, with debt/equity at 0.8x and net debt/EBITDA at 1.6x.
DD’s distorted earnings base and negative revenue growth make some relative multiples less reliable as a benchmark.